Pitango

Pitango is an Israeli venture-capital firm headquartered in Tel Aviv. Founded in 1993 as Polaris Venture Capital by Rami Kalish, it developed into one of Israel's longest-established and largest venture investors. The firm backs technology and innovation-oriented companies from early development through growth stages, combining capital with operational, commercial, and strategic support. The firm's early history is closely associated with the expansion of Israel's high-technology ecosystem during the 1990s. In 1996, Chemi Peres joined Kalish in establishing Polaris Fund II, which raised more than $100 million and invested in 35 high-technology companies. In 2001, the firm adopted the Pitango name to distinguish itself from the Boston-based Polaris Venture Partners. The new name refers to the Surinam cherry, a semi-wild fruit that grows in Israel. Pitango has subsequently raised multiple venture funds and built a platform spanning early-stage, sector-focused, and growth investing. Its principal investment vehicles include Pitango First, which focuses on early-stage companies; Pitango HealthTech, which concentrates on healthcare innovation; and Pitango Growth, which targets more mature businesses. The firm has also organized its investment activity around areas such as artificial intelligence, quantum computing, cybersecurity, cloud computing, DevOps, enterprise infrastructure, financial technology, TransitTech, digital health, medical devices, biotechnology, sales and marketing technology, retail, and e-commerce. According to the referenced Wikipedia material, Pitango had raised 14 venture funds, invested in more than 300 companies, and achieved more than 90 public listings or strategic acquisitions by 2025. Reported investment outcomes include companies that became publicly traded on Nasdaq or the New York Stock Exchange, as well as acquisitions by large technology companies including Google, Apple, IBM, and Cisco. The firm's investment base has included institutional and strategic investors from the United States, Europe, Japan, and Southeast Asia, with named investors including Time Warner, Citigroup, Eastman Kodak, Deutsche Bank, and HarbourVest Partners. Pitango's portfolio examples include Via Transportation, DriveNets, AppsFlyer, Forescout, and Varonis. Its current positioning is that of a broad-based Israeli technology investor with dedicated capabilities for early-stage ventures, healthcare technology, and growth-stage businesses. The available reference material describes the firm as active and supported by a partnership, value-add, operations, support, and venture-partner structure. It does not establish a separate consumer-food business, despite the supplied country and industry fields; those fields have therefore been corrected to reflect the authoritative Wikipedia subject.

Pitango began in 1993 under the name Polaris Venture Capital. Rami Kalish established the fund during the formative period of Israel's modern venture-capital industry, when local technology companies were beginning to attract substantial international investment. The firm's initial identity was Polaris, and its early activities centered on backing high-technology businesses with growth potential. A significant early development came in 1996, when Chemi Peres joined Kalish to create Polaris Fund II. The fund raised more than $100 million and invested in 35 high-tech companies. This expansion helped establish the organization as a substantial participant in Israel's technology financing market and broadened its ability to support companies across multiple stages of development. In 2001, the Israeli firm changed its name from Polaris Venture Capital to Pitango Venture Capital. The change was intended to prevent confusion with the Boston-based Polaris Venture Partners. The Pitango name was drawn from the Surinam cherry, a semi-wild fruit found in Israel. The rebranding gave the firm a distinct identity while retaining its focus on venture investment. Over the following years, Pitango expanded its fund platform, partnership, and support functions. The firm developed dedicated investment approaches for early-stage companies, healthcare technology, and growth-stage businesses. These activities were later represented by Pitango First, Pitango HealthTech, and Pitango Growth. Its investment scope also widened beyond conventional software to include deep technology, artificial intelligence, cybersecurity, cloud and enterprise infrastructure, financial technology, mobility, digital health, medical devices, biotechnology, commerce, and sales and marketing systems. The firm reported a broad record of portfolio activity. By 2025, the referenced material stated that Pitango had raised 14 venture funds, invested in more than 300 companies, and helped produce more than 90 companies that either became publicly traded on Nasdaq or the New York Stock Exchange or were acquired by strategic buyers. Examples of strategic acquirers cited in the reference include Google, Apple, IBM, and Cisco. Companies identified as notable Pitango investments include Via Transportation, DriveNets, AppsFlyer, Forescout, and Varonis. Pitango's capital base has included institutional and strategic investors from North America, Europe, Japan, and Southeast Asia. The cited investor list includes Time Warner, Citigroup, Eastman Kodak, Deutsche Bank, and HarbourVest Partners. The reference material also describes a 2020 fund vintage of $750 million and more than $3 billion under management as of 2025; these figures are included below only with their stated time context and source. The firm's present structure includes partners, venture partners, a value-add team, and operations and support personnel. Its role remains that of a multi-stage investor supporting Israeli and internationally oriented innovation companies.

1. 2025The firm reports a large multi-fund platform

   The referenced material states that Pitango had raised 14 venture funds, invested in more than 300 companies, and managed more than $3 billion.

   Source
2. 2020A $750 million fund vintage is reported

   The referenced material identifies a 2020 fund vintage of $750 million and describes it as the largest venture group fund in Israel at that time.

   Source
3. 2001The firm adopts the Pitango name

   Polaris Venture Capital changed its name to Pitango Venture Capital to avoid confusion with a Boston-based firm using the Polaris name.

   Source
4. 1996Polaris Fund II is established

   Chemi Peres joined Kalish in creating Polaris Fund II, which raised more than $100 million and invested in 35 high-technology companies.

   Source
5. 1993Polaris Venture Capital is founded

   Rami Kalish founded the venture-capital firm that initially operated as Polaris Venture Capital.

   Source

An Israeli multi-stage venture-capital platform focused on technology and innovation-driven companies, with dedicated early-stage, healthcare, and growth investment practices.

• Pitango FirstEarly-stage venture capital

  Pitango First is the firm's early-stage investment platform. It is designed for young technology companies and entrepreneurs developing new products, platforms, or infrastructure. The platform sits at the front end of Pitango's investment model and complements the firm's later-stage and sector-specialist activities. The available reference material does not specify its fund size, launch date, or complete investment criteria.

• Pitango HealthTechHealthTech venture capital

  Pitango HealthTech is the firm's healthcare-focused investment platform. Its stated areas include digital health, medical devices, and biotechnology. The platform gives Pitango a dedicated structure for businesses subject to healthcare development, regulatory, clinical, and commercialization requirements. Specific fund size, launch date, and portfolio limits are not established by the supplied reference material.

• Pitango GrowthGrowth-stage venture capital

  Pitango Growth focuses on more mature companies requiring capital and support for expansion. It complements the firm's early-stage activity by addressing businesses that have progressed beyond initial formation and may be scaling their products, sales, infrastructure, or international operations. The available source does not provide a launch year, fund size, or detailed stage thresholds.

• 2001Rename Polaris Venture Capital as Pitango Venture CapitalStrategy

  The Israeli firm shared the Polaris name with a Boston-based venture firm, creating a risk of confusion despite the Israeli firm's earlier founding date.

  What changed. The firm changed its name to Pitango Venture Capital. The new name referred to the Surinam cherry found in Israel.

  Aftermath. The renamed organization continued expanding its venture funds and investment platform under the Pitango identity.

  Source

1. Pitango